Pérez-Cuadrado-Robles Enrique, Ferreira Alexandre, García-Cano Jesús
Gastroenterology, Cliniques universitaires Saint-Luc, Belgium.
Gastroenterology, Hospital Beatriz Ângelo, Portugal.
Rev Esp Enferm Dig. 2018 Apr;110(4):215-216. doi: 10.17235/reed.2018.5502/2017.
During the last years, there is more and more scientific evidence about the safety and feasibility of non-anesthesiologist administration of propofol (NAAP) in gastrointestinal endoscopy, reducing sedation induction and recovery time as well as increasing patient and endoscopist satisfaction. Furthermore, a similar risk of adverse events compared with traditional agents or anesthesiologist administration of propofol (AAP) has been described. The present special issue of the Spanish Journal of Gastroenterology (Revista Española de Enfermedades Digestivas) focusses on NAAP in different settings, including complex endoscopic procedures.
在过去几年中，越来越多的科学证据表明，在胃肠内镜检查中由非麻醉医生实施丙泊酚给药（NAAP）具有安全性和可行性，可缩短镇静诱导和恢复时间，并提高患者及内镜医生的满意度。此外，与传统药物或由麻醉医生实施丙泊酚给药（AAP）相比，NAAP出现不良事件的风险相似。《西班牙胃肠病学杂志》（《Revista Española de Enfermedades Digestivas》）的本期特刊聚焦于不同场景下的NAAP，包括复杂的内镜检查程序。
